Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Upidosin (SB-216469) is a potential uroselective α1-adrenoceptor antagonist, α1a subtype Ki=0.34 nM, α1b subtype Ki=3.9 nM, α1d subtype Ki=1.5 nM, α2-adrenoceptor Ki=33.3 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 62.00 | |
10 mg | In stock | $ 93.00 | |
25 mg | In stock | $ 153.00 | |
50 mg | In stock | $ 219.00 | |
100 mg | In stock | $ 328.00 | |
200 mg | In stock | $ 493.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 84.00 |
Description | Upidosin (SB-216469) is a potential uroselective α1-adrenoceptor antagonist, α1a subtype Ki=0.34 nM, α1b subtype Ki=3.9 nM, α1d subtype Ki=1.5 nM, α2-adrenoceptor Ki=33.3 nM. |
Synonyms | SB-216469, SB 216469, Rec 15-2739, Recordati 15/2739 |
Molecular Weight | 511.61 |
Formula | C31H33N3O4 |
CAS No. | 152735-23-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.12 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Upidosin 152735-23-4 GPCR/G Protein Neuroscience Adrenergic Receptor SB-216469 SB216469 SB 216469 Rec 15-2739 Recordati 15/2739 inhibitor inhibit